Bacterial Vaginosis Rapid Test Kit core Chromogenic Ingredient IBX-4041
IBX-4041 Testing vessel
BV Blue active ingredient
BVBlue active ingredient
BVBlue substrates
BV Blue substrates
Chromogenic substrate IBX-4041
chromogenic substrate of sialidase enzyme
Detection reagent for bacterial vaginosis (sialidase two-step method)
Shenzhen BST Science & Technology Co., Ltd sells and exports chromogenic substrate of sialidase enzyme IBX-4041.
Specification:
Appearance: Light yellow solid powder
Purity: 95% min
Application: Two-step chromogenic substrates of neuraminidase (sialidase)
BVBLUE Test Kit Component
1)BVBLUE Developer Solution: Water and Sodium hydroxide
2) BVBLUE Testing Vessel: Water, Potassium acetate, IBX-4041 (chromogenic substrate compound).
IBX-4041 is the key ingredient of BVBLUE test kit, BVBLUE test is a rapid sialidase test for bacterial vaginosis. BVBLUE test method is currently the only test method approved by the FDA for testing Bacterial Vaginosis(BV), The BV BLUE Test contains a chromogenic substrate of sialidase enzyme, IBX-4041.
BV Blue test is a commercially available test, it detects sialidase activity, an enzyme produced by BV-associated bacteria such as Gardnerella vaginalis, Bacteroides spp., Prevotella spp., and Mobiluncus spp. In the test procedure, a vaginal fluid sample is placed in the test vessel which contains a chromogenic substrate for sialidase. After incubation, a developer solution is added, and If the sample contained a high level of sialidase, a blue or green color is seen. Samples containing no sialidase, or low levels of this enzyme, will generate a yellow color in the reaction. The BV test has high specificity and sensitivity. The BVBlue test enables rapid detection of BV in a physician's office, and can thereby provide advantages over the Amsel methods and other methods requiring extensive laboratory testing.
Advantage of BVBLUE Test Kit
Compared to other diagnostic test methods for BV such as Amsel criteria, Nugent Gram-stain scoring system, Affirm�® Microbial Identification Test, BVBLUE Test Kit has following advantage:
1, BVBLUE Test is currently the only test method approved by the FDA for testing Bacterial Vaginosis(BV).
2, BVBLUE Test just take 10 minutes to 15 minutes to get the result.
3, High purity sialidase substrate with high specificity can reduce the occurrence of false positive.
4. Comparing with the gold standard, the coincidence rate is high, the relative sensitivity is 93%, and the specificity is 95%.
5. Easy to operate, do not need equipment.
6. The specimen does not need to pretreat.
The One Step Microalbumin Test Cassette (Urine) is intended for the qualitative detection of human serum albumin (HSA) in human urine specimens, as a screening test and as an aid in the diagnosis of renal dysfunction. This assay provides only a preliminary result. Clinical expertise and professional judgment should be sought to further evaluate the result of the test.
The IgM rapid Test Cassette (Serum/Plasma) is a lateral flow chromatographic immunoassay for the qualitative detection of IgM antibodies in human serum to Rheumatoid Factor (RF) antigen. It is intended to be used as ascreening test and as an aid in the diagnosis of rheumatoid arthritis. Any reactive specimen with the RF IgM Rapid Test Cassette must be confirmed with alternative testing method(s) and clinical findings.
Monkeypox IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma)
is a solid phase immunochromatographic assay for the rapid, qualitative
and differential detection of IgG and IgM antibodies to monkeypox virus
in human whole blood, serum or plasma. This test provides only a
preliminary test result.
Packing Specifications
The kit is an in vitro immunochromatographic assay for the qualitative detection of Cov19, Influenza A and Influenza B virus antigens in human nasopharyngeal, oropharyngeal swab, and salvia samples.
Cov19 is an acute respiratory infectious disease that humans are easily infected with. According to current epidemiological investigations, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms are: fever, fatigue, dry cough, in a few cases can appear nasal congestion, sore throat, myalgia and diarrhea. Influenza, often called the flu is caused by the influenza virus. It is a highly contagious viral infection of the respiratory tract that can be spread by coughing or sneezing. Influenza outbreaks occur every fall and winter. There are influenza A, B and C viruses. Influenza A viruses are more prevalent than influenza B and Cand causes more severe illness.
Cov19 infection and Influenza virus infection have similar symptoms, such as fever, cough, etc. This kit can simultaneously detect the antigens of the three viruses and provides an easy workflow, short turnaround time, and rapid diagnosis of Cov19, Influenza A and influenza B virus infections using nasopharyngeal, oropharyngeal swab or salvia samples.
The kit is an immunochromatographic assay,based on double antibody sandwich method to detect Cov19 and Influenza A/B virus antigens. This method does not require expensive medical instruments and consumables. After adding the extracted specimen to the sample well on the test cassette, Cov19, Influenza A/B virus antigens in the sample will interact with the colloidal gold-labeled anti-CoV-2 and Influenza A/B antibodies on the conjugate pads. Then the conjugate pad will release re-solubilized conjugate onto the nitrocellulose membrane. The nitrocellulose membrane (NC membrane) diffuses it forward.
As the sample moves along the device binding reagents situated on the nitrocellulose membrane bind to the target at the test line. If the sample contains a COV19 antigen, it will bind to the colloidal goldanti-CoV-2 Np monoclonal antibody, diffuse forward, and then react with the anti-CoV-2 Np monoclonal antibody immobilized on the NC membrane detection line (COV19 Test line). Similarly, if the specimen contains Influenza A/Influenza B antigens, the antigens will react with antibody-coated particles, the conjugate migrate laterally forward, and cause a colored lines (A, B linesrespectively).
Product Name
Neutrophil Gelatinase-Associated Lipid Carrier Protein (NGAL)Test Kit (Immunofluorescence Chromatography)
Purpose
To detect the NGAL in human plasma/serum/whole blood in vitro quantitatively.For Professional Use only.
Principles of Detection
The NGAL Test is a fluorescent lateral flow immunoassay. The test consists of: 1) a conjugate pad containing NGAL antibody conjugated with fluorescent microspheres and a control antibody (goat anti-chicken IgY antibody) conjugated with fluorescence microspheres, 2) a nitrocellulose membrane strip containing a test line (T line) and a control line (C line). The T line is pre-coated with anotherNGAL antibody, and the C line is pre-coated with a control line antibody (chicken IgY antibody).
NGAL concentration in specimen is positively correlated with the fluorescent density of the microspheres, after the measure and calculation of the quantitative fluorescence immunoassay analyzer, then the analyzer would calculate the concentration of NGAL according to the preset calibration curve in the machine and display the result, detection unit is ng/mL. C line should appear in any cases, which indicates the reaction system is effective.
Reference range
Reference value: 37-180ng/mL; The reference value is verified by referring to similar products on the market. Due to ethnic and regional differences, each laboratory can establish its own reference interval according to the actual situation.
Novel Coronavirus (2019-nCoV) Real-time RT-PCR Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in oropharyngeal swabs and bronchoalveolar lavage fluid collected form individuals suspected of COVID-19 by their healthcare provider.
About SARS-CoV-2
Specific antibodies will be produced within days to weeks as the immune system makes immune defense against the SARS-CoV-2 infection. Total antibody detection is an aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical symptoms and result of other diagnostic methods. The test result should not be used as the sole basis for diagnosis and exclusion of SARS-CoV-2 infection. Total antibody may not be detected in the first few days of infection.
SARS-CoV-2 neutralizing antibody is a protective soluble protein secreted by adaptive immunizing cells after inoculation with SARS-CoV-2 vaccine or infection with SARS-CoV-2. These antibodies can specific bind with virus RNA binding domain (RBD) to block the binding of RBD with angiotensin-converting enzyme 2 (ACE2) on human cells surface, thus prevent the virus or its genetic material into the human cell and virus infection.
Benifits of the Kit
1) Room Temperature Transportation
2) Cost-Effective Shipping
The shipping is at room temperature, with no need of cold chain shipping.
3) Highly Sensitive, Highly Specific
Highly sensitive and highly specific for 2019-nCoV, reliable identification of COVID-19.
4) Environmentally Friendly
The kit needs neither bulky packaging nor cold chain shipping.
For the detection of eye / nose / stool / rectal secretions or blood pathogens
The most convenient and rapid diagnostic tool for canine distemper / canine parvovirus
Feature
High accuracy for monoclonal antibody capture target
Good tools for antibody detection and disease diagnosis
Easiest reagent to operate the test
Quickly present the result
Low testing cost
Technical specification
Technical Parameters for Rapid Canine Distemper Ag Test Kit
Principle: colloidal gold lateral chromatography
Test samples: eye / nasal secretions or blood
Interpretation of time: 10-15 minutes
Sensitivity: 98%
Specificity: 97%
Shelf life: 24 months
Storage temperature: 4-28
Packing: 10 Test/ box
Technical Parameters for Rapid Feline Parvovirus Ag Test Kit
Antigen Detection Rapid Lateral Flow Test (latex bead-based)
AIVD Biotech's Ag test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein (NP) antigen in direct nasal swabs from individuals suspected of infection.
Description:
This kit utilizes the principle of latex bead immunochromatography to qualitatively detect the Np antigen in human nasal swabs. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of suspected patients.
The test contains latex bead conjugate pad and a membrane strip pre-coated with antibodies specific to the antigen on the test lines (T). If novel NP antigen is present in the specimen, a visible band appears on the test lines (T) as antibody-antigen-antibody latex bead complex forms. The control line (C) is used for procedural control and should always appear if the test is performed correctly.
This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well. If sample contains the antigen, it will interact with the latex bead-labeled anti- NP antibodies on the conjugate pad.
Required components
1. A foil pouch with a desiccant and a single use test card, 1 piece
3. Sterile swab, 1 piece
3. Extraction buffer tube (1 ml), 1 tube.
4. Instructions for use, 1 piece.
Storage conditions
1. Store at the dark place, room temperature 18~28C with low humidity.
2. After opening the foil bag, please use the test cassette within 30 mins.
3. Expiration period 12 month
2.Specimen should be tested as soon as possible upon collection. If the sample has to be stored, store the swab sample at room temperature for up to 1 hour or 2~8C for up to 4 hours prior to testing.
Performance Characteristics
A total of 365 samples from suspected patients were tested by the RT-qPCR test. Testing results are shown in the following table:
PCR
AIVD Antigen Rapid Test Kit Positive Negative
Positive 59 8
Negative 6 292
Total: 65 300
